Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease

Background: The emergence of new SARS-CoV-2 variants calls for more data on SARS-CoV-2 mRNA vaccine response. Aims: We aimed to assess the response to a third mRNA vaccine dose against SARS-CoV-2 in inflammatory bowel disease (IBD) patients. Methods: This was a single-center, observational prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsipotis, Evangelos, Maremanda, Ankith, Zeiser, Laura Bowles, Connolly, Caoilfhionn, Sharma, Sowmya, Dudley-Brown, Sharon, Frey, Sarah, Lazarev, Mark, Melia, Joanna M., Parian, Alyssa M., Segev, Dorry L., Truta, Brindusa, Yu, Huimin, Werbel, William A., Selaru, Florin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456461/
https://www.ncbi.nlm.nih.gov/pubmed/37629777
http://dx.doi.org/10.3390/medicina59081487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456461/
https://www.ncbi.nlm.nih.gov/pubmed/37629777
http://dx.doi.org/10.3390/medicina59081487

Ejemplares similares